XML 80 R19.htm IDEA: XBRL DOCUMENT

STOCK WARRANTS

6 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

The following is a summary of stock warrant activity during the six months ended March 31, 2020.

		Number of Warrant Shares				Weighted Average Exercise Price
Balance, September 30, 2019			1,314,063			$	21.62
Warrants granted			—			$	—
Warrants expired			—				—
Warrants canceled			—				—
Warrants exercised			—				—
Balance, March 31, 2020			1,314,063			$	21.62

As of March 31, 2020, the outstanding warrants have a weighted average remaining term of was 2.40 years and an intrinsic value of $88,500.

As of March 31, 2020, there are warrants exercisable to purchase 1,282,636 shares of common stock in the Company and 31,429 unvested warrants outstanding that cannot be exercised until vesting conditions are met. 996,198 of the warrants require a cash investment to exercise as follows, 5,000 required a cash investment of $8.00 per share, 449,865 require a cash investment of $15.00 per share, 125,000 require a cash investment of $20.00 per share, 103,000 require a cash investment of $25.00 per share, 200,000 require an investment of $35.00 per share, 10,000 require an investment of $40.00 per share, 60,000 require an investment of $50.00 per share, 38,333 require a cash investment of $75.00 per share and 5,000 require a cash investment of $100.00 per share. 317,865 of the outstanding warrants contain provisions allowing a cashless exercise at their respective exercise prices.

Warrant activity for the six months ended March 31, 2019

On October 15, 2018, the Company entered into an agreement with a consultant for services. Under this agreement the Company agreed to issue 3,000 warrants to purchase shares of the Company’s common stock at an exercise price of $25.00 for a period of five years which vest evenly over a six-month period from the agreement date. During the six months ended March 31, 2020 and 2019 the Company recorded stock compensation of $0 and $68,643 as a result of the stock issued under the agreement. The warrants were valued using the black-Scholes valuation model.

On December 31, 2018, in connection with a Securities purchase agreement (see Note 9 for additional details) the Company issued Common Stock Purchase Warrants to acquire up to 308,333 shares of common stock for a term of three years on a cash-only basis at an exercise price of $20.00 per share with respect to 125,000 Warrant Shares, $25.00 with respect to 100,000 Warrant Shares, $50.00 with respect to 50,000 Warrant Shares and $75.00 with respect to 33,333 Warrant Shares.

On August 28, 2018, in connection with the Consulting agreement executed with Zero Positive, LLC the Company issued warrants to purchase 90,000 shares of common stock at an exercise price of $8.00 per share to Zero Positive. The warrants were valued at $2,607,096 using the Black Scholes option pricing model. The warrants vest as follows: 30,000 warrants vested immediately, the balance vest evenly on the last day of each month over the forty-two months beginning August 31, 2018. As of March 31, 2020, 58,571 warrants had vested, and the Company recorded an expense of $248,295 and 248,295 during the six months ended March 31, 2020 and 2019. (See Note 9 for additional details.)

On January 22, 2019, in accordance with a merger agreement, CleanSpark issued; a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $16.00 per share, and a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $20.00 per share. The warrants were valued at $1,102,417 and $1,102,107, respectively.

The Black-Scholes model utilized the following inputs to value the warrants granted during the six months ended March 31, 2019:

Fair value assumptions – Warrants:		March 31, 2019
Risk free interest rate		2.46% -3.01%
Expected term (years)		3-5
Expected volatility		265-268%
Expected dividends		0%

On January 7, 2019, a total of 144,417 shares of the Company’s common stock were issued in connection with the cashless exercise of 150,000 common stock warrants at an exercise price of $0.83.

On February 26, 2019, a total of 24,628 shares of the Company’s common stock were issued in connection with the cashless exercise of 25,000 common stock warrants at an exercise price of $0.83.

On March 26, 2019, a total of 48,857 shares of the Company’s common stock were issued in connection with the cashless exercise of 50,000 common stock warrants at an exercise price of $0.83.

As of March 31, 2020, the Company expects to recognize $910,415 of stock-based compensation for the non-vested outstanding warrants over a weighted-average period of 1.8 years.